{"ModuleTitle": "Company Description", "CompanyName": "Cytokinetics, Incorporated", "Symbol": "CYTK", "Address": "280 EAST GRAND AVENUE ., SOUTH SAN FRANCISCO, California, 94080, United States of America", "Phone": "(650) 624-3000", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "When used in this report, unless otherwise indicated, \"Cytokinetics,\" \"Company,\"\r\n\"we,\" \"our\" and \"us\" refers to Cytokinetics, Incorporated. CYTOKINETICS, and our\r\nlogo used alone and with the mark CYTOKINETICS, are registered service marks and\r\ntrademarks of Cytokinetics. Other service marks, trademarks and trade names\r\nreferred to in this report are the property of their respective owners.\r\n\r\n                                        \r\n\r\n                                       2\r\n\r\n \r\n\r\n--------------------------------------------------------------------------------\r\n \r\n\r\nOverview\r\n\r\nWe are a late-stage biopharmaceutical company focused on discovering, developing\r\nand commercializing first-in-class muscle activators and next-in-class muscle\r\ninhibitors as potential treatments for debilitating diseases in which muscle\r\nperformance is compromised and/or declining.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f04%2f0001564590-20-008694.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Andrew A. Wolff", "title": "Senior VP-Clinical Research & Development"}, {"name": "Ching W. Jaw", "title": "Chief Financial Officer & Senior Vice President"}, {"name": "Daniel R. Casper", "title": "Vice President-Information Technology"}, {"name": "Fady Ibraham Malik", "title": "Executive Vice President-Research & Development"}, {"name": "Robert I. Blum", "title": "President, Chief Executive Officer & Director"}, {"name": "Stuart Kupfer", "title": "Chief Medical Officer & Senior Vice President"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}